Dec 5, 2016 07:08AM
Dec 2, 2016 01:11PM
Nov 30, 2016 05:29PM
Nov 30, 2016 05:28PM
Nov 29, 2016 07:36AM
Nov 23, 2016 08:01AM
Nov 23, 2016 06:45AM Eli Lilly & Co. (LLY) Announces Solanezumab Phase 3 in Alzheimer's Disease Missed Primary Endpoint
Nov 14, 2016 06:31AM
Nov 11, 2016 07:14AM
Nov 10, 2016 07:01AM
Nov 9, 2016 04:06PM
Nov 9, 2016 06:41AM
Nov 7, 2016 04:32PM
Nov 7, 2016 06:05AM Cempra (CEMP) Announces Receipt of Positive FDA AdCom Vote on Solithromycin in CABP
Nov 3, 2016 05:09PM
Nov 3, 2016 09:09AM
Nov 1, 2016 04:33PM
Oct 28, 2016 02:36PM
Oct 28, 2016 08:34AM
Oct 27, 2016 11:44AM
Oct 24, 2016 04:25PM Global Blood Therapeutics (GBT) Reaches Agreement with FDA on Design of Phase 3 GBT440 Trial in SCD
Oct 24, 2016 08:02AM
Oct 24, 2016 08:01AM
Oct 20, 2016 04:01PM
Oct 20, 2016 07:02AM
Oct 19, 2016 03:54PM
Oct 19, 2016 01:57PM
Oct 17, 2016 07:11AM Omeros' (OMER) OMS721 Phase 2 Trial Achieves Key Endpoints
Oct 17, 2016 07:05AM
Oct 11, 2016 10:02AM
Oct 7, 2016 11:00AM
Oct 7, 2016 08:46AM
Oct 5, 2016 04:31PM
Sep 29, 2016 05:42PM
Sep 29, 2016 04:56PM Aurinia Pharmaceuticals (AUPH) Says Voclosporin Achieves Primary, Secondary Endpoints in Phase IIb Study for LN
Sep 29, 2016 04:02PM
Sep 29, 2016 09:04AM
Sep 29, 2016 07:32AM
Sep 29, 2016 07:26AM
Sep 28, 2016 04:41PM
Sep 28, 2016 04:33PM
Sep 27, 2016 04:14PM Galectin (GALT) Reports Exploratory Phase 2a Pilot Trial of GR-MD-02 in Nash Misses Primary Biomarker Endpoint; Announces $1.5M Private Placement
Sep 27, 2016 06:37AM
Sep 26, 2016 04:02PM
Sep 26, 2016 09:43AM
Sep 26, 2016 07:55AM
Sep 26, 2016 07:03AM
Sep 23, 2016 04:11PM
Sep 23, 2016 11:52AM Achillion Pharma (ACHN) Announces Positive SVR12 Data for Odalasvir, AL-335, and Simeprevir Phase 3 in Genotype 1 HCV
Sep 22, 2016 08:02AM

970 total articles have been posted to this category.

Sign-up to StreetInsider.com Premium to see all today's market moving Hot FDA News reports.